Target intelligence / Profile preview

Oral cavity bacterium

Molecular classification
Other
01

Overview

Oral cavity bacteria comprise a highly complex, site-specific community of microorganisms inhabiting the human mouth, with over 700 described species spanning at least 12 bacterial phyla, such as Firmicutes, Proteobacteria, Actinobacteria, Bacteroidetes, and Fusobacteria[1][3][5]. These bacteria exist in symbiotic equilibrium, contributing to oral and general health, but shifts in composition (dysbiosis) can trigger oral and systemic diseases, including dental caries, periodontitis, and links to cardiovascular and metabolic disorders. Intervention strategies are shifting toward selective targeting of pathogenic bacteria or restoration of healthy communities through probiotics or microbiota transplantation, rather than broad-spectrum microbial eradication[2][4][6].

Other names
oral microbiotaoral microbiomeoral florahuman oral bacterial community
02

Mechanism of action

Broad-spectrum antimicrobial action (disrupting or killing diverse oral bacteria) Targeted eradication of dysbiotic/pathogenic bacteria (e.g., inhibition of glucan synthesis in *S. mutans*) Probiotic colonization and competitive exclusion of pathogens Biofilm modulation Immunomodulation

03

Biological functions

Maintenance of oral ecological balanceParticipation in biofilm formationModulation of host immunityDigestion of nutrientsPrevention (or promotion, in dysbiosis) of pathogenic colonization
04

Disease associations

Infection (e.g., periodontitis, dental caries, halitosis, endodontic infections)Inflammation (e.g., gingivitis, periodontitis)Associated with systemic diseases when dysbiosis occurs (e.g., cardiovascular disease, diabetes, inflammatory bowel disease)
05

Safety considerations

Broad-spectrum antibiotics may disrupt commensal populations and select for resistant strainsProbiotics may not persist or may be ineffective in specific oral environmentsMicrobiota transplantation raises concerns about pathogen transfer
06

Interacting drugs

Antimicrobials (e.g., chlorhexidine, amoxicillin)

3 more in the full profile.

07

Biomarkers

Presence/abundance of specific species (e.g., *S. mutans* for caries risk, *P. gingivalis* for periodontitis risk)Salivary microbiome composition and diversityMicrobial metabolites (e.g., acids, volatile sulfur compounds)

Beyond the preview

Go deeper on Oral cavity bacterium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oral cavity bacterium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call